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http://dxObjectives: We undertook a single-center, 12 years outcomes analysis of the influence of bilateral internal
mammary arteries (BIMA) over single internal mammary artery (SIMA) on short-term outcomes and
long-term outcomes bymeans of propensity scorematching technique in accordance to current recommendations.
Methods: A propensity score was generated for each patient from a multivariable logistic regression model
based on 20 pretreatment covariates. The study population consisted of 4195 patients undergoing coronary
artery bypass graft procedure using SIMA (n ¼ 3445; 78.3%) or BIMA (n ¼ 750; 21.7%). A total of 750
matching sets were derived.
Results: The BIMA group was associated with an increased rate of superficial sternal wound infection (5.6% vs
1.7%; P ¼ .0001) but the incidence of deep sternal wound infection was comparable between the 2 groups, at
2.1% and 1.5% in BIMA and SIMA groups, respectively (P ¼ .43). With regard to other postoperative
complications the 2 groups were comparable. Operative mortality rate did not significantly differ between the
2 groups, at 0.7% and 1.2% in the BIMA and SIMA groups, respectively (P ¼ .28). After a mean follow-up
time of 4.8 3.2 years, BIMA use was associated with a significantly lower risk for late mortality (hazard ratio,
0.61; 95% confidence interval 0.38-0.97;P¼ .03) and need for repeat revascularization (hazard ratio, 0.75; 95%
confidence interval, 0.53-0.96; P ¼ .03).
Conclusions: When compared with SIMA grafting, BIMA use did not increase operative morbidity and
mortality and was associated with a better long-term survival. (J Thorac Cardiovasc Surg 2014;148:2699-705)A
C
DThe use of bilateral internal mammary arteries (BIMA)
compared with single internal mammary artery (SIMA)
use has been proposed to improve late survival in patients
undergoing coronary artery bypass graft (CABG) proce-
dure.1 This survival advantage from BIMA use is currently
supported by several observational cohort studies2 because
the only randomized controlled trial to date evaluating
long-term survival and freedom from reintervention from
BIMA is still ongoing.3 However observational studies
often have several methodologic flaws that limit the
usefulness of their conclusions.4
Propensity score (PS) matching, which creates groups of
patients who have similar pretreatment characteristics when
treatment assignment is not random, has emerged as the
most effective statistical method to reduce bias in treatmenthe Department of Cardiac Surgery, Harefield Hospital, London, United
dom.
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The Journal of Thoracic and Carcomparisons in observational studies.5-7 With regard
to BIMA use, only 4 out of 27 observational studies
included in a recent systematic review2 using PS matching
demonstrated a survival benefit from BIMA.8-11 Moreover
surgeons continue to be reluctant to use BIMA routinely
because concerns still exist regarding the detrimental
effect of this strategy on operative outcomes,12 including
the increased risk for sternal wound complications.13 There-
fore there is an urgent need for additional well-conducted
studies to validate the safety and efficacy of BIMA grafting
and enhance its universal adoption.
Recently general recommendations have been proposed
in conducting PS matching.5-7 We undertook a single-
center, 12 years outcomes analysis using the PS matching
technique in accordance with current recommendations to
evaluate the influence of BIMA over SIMA on short- and
long-term outcomes.
METHODS
Study Population
The study was conducted in accordance with the principles of the
Declaration of Helsinki. The local ethics committee approved the study,
and the requirement for individual patient consent was waived. We
retrospectively analyzed prospectively collected data from an institutional
surgical database (Dendrite Clinical Systems, Ltd, Oxford, UK) from April
2001 to May 2013. The database captures detailed information on a widediovascular Surgery c Volume 148, Number 6 2699
Abbreviations and Acronyms
BIMA ¼ bilateral internal mammary arteries
CABG ¼ coronary artery bypass graft
DWSI ¼ deep sternal wound infection
LAD ¼ left anterior descending
LVEF ¼ left ventricular ejection fraction
PCI ¼ percutaneous coronary intervention
PS ¼ propensity score
PVD ¼ peripheral vascular disease
SIMA ¼ single internal mammary artery
SSWI ¼ superficial sternal wound infection
SVG ¼ saphenous vein grafts
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(including complications and mortality) for all patients undergoing
CABG in our institution. The data is collected and reported in accordance
with the Society for Cardiothoracic Surgery in Great Britain & Ireland
database criteria. The database is maintained by a team of full-time clinical
information analysts who are responsible for continuous prospective data
collection as part of a continuous audit process. Data collection is validated
regularly. Information about death from any cause is regularly obtained
from the General Register Office approximately 1 week after the event
and data on repeat revascularization is collected from a national surgical
and interventional database.
Patients included in the final analysis met the following criteria:
first-time isolated CABG, 2 grafts received, and surgical strategies
included single left internal mammary artery to left anterior descending
(LAD) artery and additional saphenous vein grafts (SVG) for non-LAD
targets (SIMA group) or BIMA with or without additional SVG (BIMA
group). Internal mammary arteries were harvested as pedicled or skeleton-
ized conduit according to surgeon preference. Antibiotic prophylaxis
included 2 g cefazolin administrated intravenously between 20 to 30
minutes after the induction of anesthesia, followed by 1 g every 8 hours
for 24 hours. For all interventions lasting>3 hours, a new dose of 1 g
cefazolin was administered. All patients had strict blood glucose control
according to a unique intravenous insulin therapy protocol. The target
blood glucose was 100 to 139 mg/dL (5.5-7.7 mmol/L). Blood glucose
monitoring began upon the arrival of the patient to the operating room.
Blood glucose measurements were taken hourly during the intraoperative
period and after admission to our intensive care unit until a stable blood
glucose level within the blood glucose target range was achieved.
Blood glucose was then checked every 3 hours. Depending on the
patient’s clinical condition, oral intakes were initiated as soon as
possible postoperatively. Intravenous insulin therapy was replaced by
subcutaneous insulin when either oral feeding was initiated or 2 days
postoperatively.
Pretreatment Variables and Study End Point
The effect of BIMA was adjusted for the following 20 pretreatment
variables: age, female gender, New York Heart Association functional
class III to IV, prior myocardial infarction prior percutaneous coronary
intervention (PCI), diabetes mellitus, current smoking, chronic obstructive
pulmonary disease, cerebrovascular accident, peripheral vascular disease
(PVD), history of atrial fibrillation, number of vessels diseased, left main
stem disease, left ventricular ejection fraction (LVEF) <50%, renal
impairment defined as a serum creatinine>200 mmol/L, obesity defined
as body mass index 30, urgent/emergent indication, preoperative use of
intra-aortic balloon pump, surgery performed by a resident physician,
and the use of cardiopulmonary bypass.2700 The Journal of Thoracic and Cardiovascular SurThe short-term outcomes investigated were the incidence of superficial
sternal wound infection (SSWI) and deep sternal wound infection
(DSWI) as defined by the Centers for Disease Control and Prevention,14
postoperative cerebrovascular accident, need for renal replacement therapy,
reintubation for acute respiratory failure, reexploration for bleeding,
postoperative atrial fibrillation, and operative mortality (within 30 days).
Long-term outcomes investigated were all-cause late mortality and need
for repeat revascularization, including PCI and/or redo CABG. All-cause
death is considered the most robust and unbiased index because no
adjudication is required, thus avoiding inaccurate or biased documentation
and clinical assessments.15
Statistical Analysis
The authors adhered to guidelines16 for reporting observational studies.
For baseline characteristics, variables are summarized as mean for
continuous variables and proportion for categorical variables.
Multiple imputation using bootstrapping-based expectation-maximization
algorithm was used to address missing data.17 To control for measured
potential confounders in the data set, PS was generated for each patient from
a multivariable logistic regression model based on 20 pretreatment covariates
as independent variables with treatment type (BIMA vs SIMA) as a binary
dependent variable.18 The resulting propensity score represented the
probability of a patient undergoing CABG with BIMA grafting. Pairs of
patients receiving BIMA and SIMAwere derived using greedy 1:1 matching
with a calliper of width of 0.2 standard deviation of the logit of the PS.7 The
qualityof thematchwasassessedbycomparing selectedpretreatment variables
in the PS-matched patient using the standardizedmean difference, bywhich an
absolute standardized difference>10% is suggested to represent meaningful
covariate imbalance.6 Analytic methods for the estimation of the treatment
effect in thematched sample includedMcNemar’s test to compare proportions.
Kaplan-Meier survival curves between treated and untreated subjects in the
matched sample were compared using a test described by Klein and
Moeschberger.6,19
R version 3.1.0 (R Foundation for Statistical Computing, Vienna,
Austria) was used for statistical analysis.RESULTS
The study population consisted of 4195 patients undergo-
ing CABG using SIMA (n ¼ 3445; 78.3%) or BIMA
(n ¼ 750; 21.7%). In the BIMA group, the right internal
mammary artery was used as in situ graft to the LAD in
456 cases. Among those, the left internal mammary artery
was used as in situ graft to the circumflex territory. A total
of 165 patients had the right internal mammary artery
grafted as in situ conduit to the circumflex territory through
the transverse sinus. The right internal mammary artery was
used as Y graft to the circumflex territory in 90 cases and as
free graft to the right coronary artery in 39 cases. In the
BIMA group, BIMAs were harvested as pedicled conduits
in 299 out of 750 patients (40%) and as skeletonized
conduits in the remaining 451 out of 750 patients (60%).
In the SIMA group, skeletonized technique was used in
1293 out of 3445 patients (37.5%).Missing Data
The fraction missing ranged from 0% (age) to 0.8%
(body mass index). Pattern of missingness in the data
were 44 and rows after listwise deletion were 3977. Rows
after imputation were 4195.gery c December 2014
TABLE 1. Pretreatment variables before and after matching in the bilateral internal mammary artery (BIMA) and single internal mammary
artery (SIMA) groups
Variable BIMA (n ¼ 750) SIMA unmatched (n ¼ 3445) P value SMD SIMA matched (n ¼ 750) P value SMD
Age (y) <.001 80 .4 3
22-50 108 14.4 136 3.9 107 14.3
50-60 252 33.6 546 15.8 250 33.3
60-70 268 35.7 1098 31.9 234 31.2
70-80 109 14.5 1379 40.0 140 18.7
80-92 13 1.7 286 8.3 19 2.5
Female <.001 28 .8 1
No 669 89.2 2713 78.8 673 89.7
Yes 81 10.8 732 21.2 77 10.3
NYHA functional class III-IV <.001 26 1 0
No 601 80.1 2367 68.7 601 80.1
Yes 149 19.9 1078 31.3 149 19.9
MI .39 4 .75 2
No 448 59.7 1997 58.0 441 58.8
Yes 302 40.3 1448 42.0 309 41.2
PCI .005 11 .63 3
No 617 82.3 2973 86.3 625 83.3
Yes 133 17.7 472 13.7 125 16.7
Smoking .09 7 1 0
No 660 88.0 3105 90.1 660 88.0
Yes 90 12.0 340 9.9 90 12.0
COPD .002 10 1 0
No 692 92.3 3080 89.4 691 92.1
Yes 58 7.7 365 10.6 59 7.9
CVA <.001 18 .74 2
No 729 97.2 3212 93.2 732 97.6
Yes 21 2.8 233 6.8 18 2.4
PVD .008 11 .82 1
No 703 93.7 3121 90.6 706 94.1
Yes 47 6.3 324 9.4 44 5.9
AF .08 8 .31 6
No 735 98.0 3332 96.7 728 97.1
Yes 15 2.0 113 3.3 22 2.9
LMD .08 7 .43 4
No 505 67.3 2432 70.6 520 69.3
Yes 245 32.7 1013 29.4 230 30.7
NVD .03 8 .96 0
1 15 2.0 78 2.3 20 2.7
2 203 27.1 770 22.4 192 25.6
3 532 70.9 2597 75.4 538 71.7
LVEF<50% <.001 23 .76 2
No 651 86.8 2685 77.9 646 86.1
Yes 99 13.2 760 22.1 104 13.9
BMI 30 .003 16 .53 4
No 521 69.5 2152 62.5 535 71.4
Yes 229 30.5 1293 37.5 215 28.6
Creatinine 200 mmol/L .059 8 .51 4
No 737 98.3 3339 96.9 741 98.8
Yes 13 1.7 106 3.1 9 1.2
DM <.001 37 .83 1
No 631 84.1 2359 68.5 635 84.7
Yes 119 15.9 1086 31.5 115 15.3
Preoperative IABP .04 9 .22 7
No 734 97.9 3317 96.3 741 98.8
Yes 16 2.1 128 3.7 9 1.2
(Continued)
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TABLE 1. Continued
Variable BIMA (n ¼ 750) SIMA unmatched (n ¼ 3445) P value SMD SIMA matched (n ¼ 750) P value SMD
Urgent/emergent .01 10 .68 2
No 536 71.5 2296 66.6 544 72.5
Yes 214 28.5 1149 33.4 206 27.5
Resident performing procedure <.001 21 .73 2
No 536 71.5 2128 61.8 529 70.5
Yes 214 28.5 1317 38.2 221 29.5
CPB <.001 15 .77 2
No 538 71.7 2235 64.9 544 72.5
Yes 212 28.3 1210 35.1 206 27.5
Values are given as n (%). SMD, Standardized mean difference; NYHA, New York Heart Association; MI, myocardial infarction; PCI, percutaneous coronary intervention;
COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; PVD, peripheral vascular disease; AF, atrial fibrillation; LMD, left main disease; NVD, number
of vessels diseased; LVEF, left ventricular ejection fraction; BMI, body mass index; DM, diabetes mellitus; IABP, intra-aortic balloon pump; CPB, cardiopulmonary bypass;
BIMA, bilateral internal mammary arteries; SIMA, single internal mammary artery.
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Table 1 summarizes for each pretreatment variable as well
as the unmatched andmatchedmeans for the treatment group
and control group with relative P value and standardizedTABLE 2. Postoperative complications in the matched bilateral
internal mammary artery (BIMA) and single internal mammary
artery (SIMA) groups
Complication
Matched BIMA
(n ¼ 750)
Matched SIMA
(n ¼ 750)
P
value
30-d death
No 745 99.3 741 98.8 .28
Yes 5 0.7 9 1.2
SSWI
No 708 94.4 737 98.3 .0001
Yes 42 5.6 13 1.7
DSWI
No 734 97.9 739 98.5 .43
Yes 16 2.1 11 1.5
Postoperative CVA
No 742 98.9 748 99.7 .11
Yes 8 1.1 2 0.3
Postoperative RRT
No 732 97.6 722 96.3 .17
Yes 18 2.4 28 3.7
POAF
No 619 82.5 604 80.5 .35
Yes 131 17.5 146 19.5
Reintervention
No 727 96.9 731 97.5 .63
Yes 23 3.1 19 2.5
Reexploration
No 718 95.7 720 96.0 .88
Yes 32 4.3 30 4.0
Hospital stay (d)
<9 581 77.5 597 79.6 .34
9 169 22.5 153 20.4
Values are given as n (%). SSWI, Superficial sternal wound infection; DSWI, deep
sternal wound infection; CVA, cerebrovascular accident; RRT, renal replacement
therapy; POAF, postoperative atrial fibrillation; BIMA, bilateral internal mammary
arteries; SIMA, single internal mammary artery.
2702 The Journal of Thoracic and Cardiovascular Surmean difference. Before matching, patients receiving SIMA
were significantly different from those receiving BIMA;
overall, 13 out of 20 pretreatment covariates showed
standardized mean difference 10%. Overall, patients
receiving SIMA presented a higher risk profile. As expected,
patients receivingBIMAwere less likely to be operated on by
resident physicians. PS matching created a total of 750
matching sets. After matching, all covariates were well
balanced between the 2 groups, with standardized mean
difference<10% for all pretreatment variables.Short-Term Outcomes
Table 2 shows the rate of postoperative complications and
operative mortality (within 30 days) in the matched sample.
The BIMA group was associated with an increased rate of
SSWI (5.6% vs 1.7%; P ¼ .0001) but the incidence of
DSWI was comparable between the 2 groups, at 2.1%
and 1.5% in the BIMA and SIMA groups, respectively
(P ¼ .43). Pedicled internal mammary artery was used in
299 (39%) and 266 (35%) in the BIMA and SIMA groups,
respectively. Among patients receiving pedicled internal
mammary artery, the incidence of SSWI was 23 out of
299 (7.6%) and 5 out of 266 (1.8%) in the BIMA and
SIMA groups, respectively (P ¼ .002) and the incidence
of DSWI was 12 out of 299 (4.0%) and 6 out of 266
(2.2%) in the BIMA and SIMA groups, respectively
(P ¼ .34). Skeletonized internal mammary artery was
used in 451 (60.1%) and 484 (64.5%) patients in the
BIMA and SIMA groups, respectively. Among patients
receiving a skeletonized internal mammary artery, the
incidence of SSWI was 19 out of 451 (4.2%) and 8 out of
484 (1.6%) in the BIMA and SIMA groups, respectively
(P ¼ .03) and the incidence of DSWI was 4 out of 451
(0.9%) and 5 out of 484 (1.0%) in the BIMA and SIMA
groups, respectively (P ¼ 1). Overall, skeletonized BIMA
was associated with a significant reduction in the incidence
of SSWI (P ¼ .04) and DSWI (P ¼ .004) when compared
with pedicled BIMA (Figure 1).gery c December 2014
FIGURE 1. Incidence of superficial sternal wound infection (SSWI) and deep sternal wound infection (DSWI) in the bilateral internal mammary artery
(BIMA) and single internal mammary artery (SIMA) groups, respectively, according to the harvesting technique.
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DWith regard to other postoperative complications the 2
groups were comparable. Operative mortality rate did not
significantly differ between the 2 groups, with 0.7% and
1.2% in the BIMA and SIMA groups, respectively
(P ¼ .28).
Total number of grafts per patients was slightly higher in
the BIMA group (2.88 grafts per patient) than in the SIMA
group (2.74 grafts per patient) (P ¼ .01).
Long-Term Outcomes
In the matched sample, the mean follow-up time was
4.8  3.2 years (maximum, 12 years). A total of 75 late
deaths were recorded, including 28 patients in the BIMA
group and 47 patients in the SIMA group, respectively. Sur-
vival probability was 98.1% 0.5% versus 96.6% 0.6%FIGURE 2. Left, Kaplan-Meier curves for overall survival. Right, repeat revas
mammary artery (BIMA) and single internal mammary artery (SIMA) groups. H
The Journal of Thoracic and Carat 1 year, 95.5%  0.8% versus 93.8%  0.9% at 5 years,
and 93.9% 1.4% versus 89.8% 1.8% at 10 years in the
BIMA and SIMA groups, respectively. Compared with
SIMA, BIMA was associated with a significantly lower
risk for late mortality (hazard ratio, 0.61; 95% confidence
interval, 0.38-0.97; P¼ .03) with an absolute risk reduction
of 39% (Figure 2, left). A total of 128 patients required
repeat revascularization, including 53 cases in the
BIMA group and 75 cases in the SIMA group. Repeat revas-
cularization free survival probability was 96.5%  0.6%
versus 95.1%  0.7% at 1 year, 91.8%  1.1% versus
90.2%  1.2% at 5 years, and 87.9%  2.0% versus
83.6% 2.2% at 10 years in the BIMA and SIMA groups,
respectively. Compared with SIMA, BIMA was associated
with a significantly lower rate of repeat revascularizationcularization-free survival in the propensity score matched bilateral internal
R, Hazard ratio.
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FIGURE 3. Hazard ratio and 95% confidence interval (CI) for long-term
mortality using bilateral internal mammary arteries and single internal
mammary artery, according to the presence of cardiovascular risk
factors, including diabetes mellitus (DM), peripheral vascular disease
(PVD), left ventricular ejection fraction (LVEF), percutaneous coronary
intervention (PCI), myocardial infarction (MI), and left main disease
(LMD).
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P ¼ .03) with an absolute risk reduction of 25%
(Figure 2, right). In a subgroup analysis (Figure 3), BIMA
was protective for late survival over SIMA regardless of
the presence of main cardiovascular risk factors, although
a trend toward an extra benefit was confirmed in patients
with LVEF<50%, PVD, and previous PCI.DISCUSSION
The main finding of our single-center PS matching
comparison was that when compared to SIMA grafting,
BIMA use was associated with comparable short-term
outcomes, including the incidence of DSWI, but a
significantly lower rate of repeat revascularization and
better long-term survival regardless of the presence of
main cardiovascular risk factors.
Despite increasing evidence from observational cohort
studies that suggest long-term survival advantages for
patients receiving BIMA grafts, only few patients currently
undergo this operation. The most often cited reason
reported by cardiac surgeons is the lack of definitive
evidence for long-term benefit from BIMA13 and the
perception that BIMA is associated with increased early
morbidity and mortality,12 specifically the occurrence of
DSWI and the well-documented increased risk of death
that accompanies it.13 Only 1 randomized trial investigating
long-term outcomes in patients receiving BIMA3 is
currently underway and results should be available by 2018.
PS matching by creating a quasirandomized study design
is increasingly being used in retrospective analyses5 to
minimize the influence of any imbalance in pretreatment
patient characteristics that affect treatment selection.6,72704 The Journal of Thoracic and Cardiovascular SurHowever, a recent systematic review on BIMA versus
SIMA found that only 4 out of 27 observational studies
using PS matching demonstrated a survival benefit from
BIMA.8-11 Locker and colleagues20 recently conducted a
PS matching between patients receiving multiple arterial
grafts, including BIMA, and patients receiving SIMA,
showing a survival advantage from BIMA. However the
multiple arterial graft group included patients receiving
the radial artery alone or in combination with a second
internal mammary artery. This aspect limits the possibility
to extrapolate the effect of BIMA per se over SIMA on
long-term survival.
Recently several recommendations have beenmade about
conducting PS matching.5-7 For meaningful conclusions,
authors reporting on PS matching comparisons are
required to provide sufficient and clear information on
how the PS was developed, the handling of missing data,
how was the PS-matched sample was created, how balance
between treatment groups was assessed, and the statistical
methods used to estimate the treatment effect.
We performed a PS matching comparison between
BIMA over SIMA grafting adhering to current recommen-
dations on PS matching.5-7 BIMA use was found to not
increase operative mortality and the incidence of major
postoperative complications, including the incidence of
DSWI. This was particularly evident when the
skeletonized technique was used to harvest the internal
mammary arteries. There is still controversy on the
detrimental effect of BIMA use on the incidence of
sternal wound infection. A recent report21 that included a
large number of patients failed to confirm BIMA use as
an independent risk factor for DSWI and our results
challenge the general notion that routine BIMA use
predisposes patients to increased risk of DSWI in particular
when the internal mammary arteries are harvested as
skeletonized conduit.22 Furthermore, it is difficult to assess
the effect of BIMA harvesting in isolation because there
was apparently little standardization of practice in relation
to stabilization of the sternum. In our study the use of
BIMA was only found to significantly increase the
incidence of SSWI even if such a detrimental effect was
mitigated by the use of skeletonized conduits.
With regard to long-term outcomes, we found that BIMA
use was associated with a significantly lower rate of repeat
revascularization and late death. The better patency rate
observed with BIMA use over SVG may partially explain
the observed long-term survival benefit.23 In addition, the
use of arterial conduits has been associated with a reduced
atherosclerotic progression in the native coronary vessels24
that might have partially contributed to the better survival
observed among patients receiving BIMA. BIMA was
found to be protective for late death regardless of the
presence of main cardiovascular risk factors, although
an extra survival benefit was observed among high-riskgery c December 2014
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previous PCI. There has been reluctance to use BIMA in
patients at higher operative risk such as those with left
ventricular dysfunction.25 Our study supports the use of
BIMA grafting among patients with left ventricular systolic
dysfunction because it may provide enhanced long-term
survival thus supporting other reports.26 Finally, the
occurrence of stent failure as well as the evidence of PVD
can identify a subset of patients with particularly aggressive
coronary atherosclerosis. Venous grafts have a high
incidence of failure among these patients,27 whereas arterial
conduits have been shown to improve angiographic and
clinical results. Therefore arterial grafts, including BIMA,
should probably be considered as the first surgical choice
in this patient population.
The principal limitation of our analysis is the inability to
address hidden biases due to unobserved or unrecorded
differences between treated and control patients before
treatment. As a consequence our results could reflect the
effects of unknown or unmeasured confounders. Moreover,
we were unable to provide specific causes of death (cardiac
vs noncardiac) and therefore we can only speculate that the
mechanism beyond the better long-term survival observed
in our BIMA group is related to the better patency rate of
the second internal mammary artery over SVG.23
CONCLUSIONS
When compared with SIMA grafting, BIMA use did not
increase the incidence of operative complications,
including DSWI, and improved long-term overall
survival and repeat revascularization-free survival. Accor-
ding to our results BIMA grafting should be strongly
recommended in patients undergoing surgical myocardial
revascularization.
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